CDEK
← All organizations

Altimmune, Inc.

For profitWebsite ↗

Also known as: Altimmune, Inc.

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 2

First clinical trial

Oct 1, 2008

Last known activity

Jun 16, 2025

Timeline

1990s

  1. Jun 1, 1997

    Altimmune, Inc.— Founded

2010s

  1. Feb 17, 2015

    Immune Targeting Systems Ltd— Acquired

  2. Jan 19, 2017

    PharmAthene— Acquired

  3. Jul 9, 2019

    Spitfire Pharma— Acquired

Drugs by trial phase (25 distinct, 30 trials)

Phase 4 (0 own, 1 via acquisition)

Indications

Studied for

Subsidiaries (3 direct, 3 total across the full acquisition tree)

Recent trials (20)

Details

Founded
Gaithersburg, MD, US Jun 1, 1997
Last known activity
Jun 16, 2025